299

3.1.1 Number of Selected Affiliate Institutions Included in Research Consortium

3.1.1.1 Establishment of the Consortium for Collaborative Research

- -

 

 

 

Management Meeting

Reguler Meeting

To evaluate research progress in CCR-ARI SHERA

Traditional (Face to Face)

2

Bandung

CCR ARI UNPAD Meeting Room

-

 

 

 

 

 

 

None

 

 

 

 

 

 

The meeting was attended by Prof. Cissy, dr. Dwi Agustian, dr. Nur Atik, dr. Chrysanti, Helmi, Selma, Ginanjar S. dr. Kuswandewi, dr. Insi, dr. Panji were not able to attend the meeting due to other task from. UNPAD.

Every research in CCR-ARI SHERA should be terminated: BOD Study should be terminated until 1 year-contract or per Desember 2019--whichever occurs earlier. Mortality study should be evaluated after a month of research, and should not be continued longer. Immunogenicity study should only be for eldery participants, and only evaluated after 28 days of vaccination. However, manuscript writing mentoring should be carried out every Thursday to increase the publication numbers for CCR-ARI SHERA. Post-discharged study should be evaluated.

N/A

N/A

Ginanjar should coordinate with Anton Guntoro regarding post dicharged data.

N/A

N/A

N/A

5

5

Fitri Devina, Yudi Andi, Joni Junaidi, Novi Akbar, Bagus Farrel, Intan Eira, Erna Laras